Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Neubase Therapeutics Inc. buy fchar99

Neubase Therapeutics Inc.
Start price
€248.59
14.07.17 / 50%
Target price
€432.96
01.12.17
Performance (%)
74.17%
End price
€432.96
01.12.17
Summary
This prediction ended on 01.12.17 with a price of €432.96. The BUY prediction by fchar99 for Neubase Therapeutics Inc. saw massive gains of 74.17%. fchar99 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Neubase Therapeutics Inc. -10.791% -10.791% -89.552% -99.563%
iShares Core DAX® 2.749% 4.620% 17.121% 21.210%
iShares Nasdaq 100 0.470% -0.331% 37.776% 57.865%
iShares Nikkei 225® -2.930% -5.556% 12.185% 8.407%
iShares S&P 500 0.679% 0.631% 28.996% 48.197%

Comments by fchar99 for this prediction

In the thread NeuBase Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 74.17%
Target price 21.648
Change
Ends at 01.12.17

fchar99 stimmt dem Sentiment von 'Buy' zu

fchar99 stimmt am 14.07.2017 dem Buy-Gesamtsentiment mit dem Kursziel 4.2$ zu.

fchar99 
0
Report Share
14.07.17
Prediction Buy
Perf. (%) 74.17%
Target price 21.648
Change
Ends at 01.12.17

(Zielkurs erreicht)

fchar99 
0
Report Share
01.12.17